Pioneering the next generation of treatment solutions
We support innovation across the continuum of care, to help to develop new technologies, treatments and vaccines.
The new Ebola clinical trial that’s focused on helping halt future outbreaks
A groundbreaking partnership between countries, health organizations and companies worldwide—including Johnson & Johnson—hopes to find the most promising vaccines to help protect people from the virus.
Featured stories
Meet the Johnson & Johnson Scientist Who’s Helping to Fight Tropical Diseases in His Homeland
Two decades after leaving India, Anil Koul has returned to helm its Institute of Microbial Technology. For Dengue Awareness Month, we caught up with him to learn how he’s hoping to combat this tropical scourge and another disease that kills over a million worldwide.
Janssen Wins Prestigious International Prix Galien Award for MDR-TB Treatment
Ground breaking therapy offers hope for people with Multi-Drug Resistant Tuberculosis (MDR-TB)
How Johnson & Johnson is helping save children around the world from intestinal worm infections
For the fifth anniversary of the London Declaration, we’re sharing the steps the company has taken to fulfill its promise to fight neglected tropical diseases—including the development of a chewable form of mebendazole.
More from Johnson & Johnson
How Johnson & Johnson is fighting counterfeit medical products
Fake medication and compromised devices are part of a global market that poses a significant threat to the health of patients. Here’s how the company’s Global Brand Protection team helps keep people safe.
What are cataracts?
If you can’t read a screen without jacking up the brightness level or if night driving leaves you seeing fuzzy halos around traffic lights, you may among the 20 million U.S. adults who develops a cataract—the most common cause of vision loss worldwide. Luckily a simple surgical procedure can have you viewing the world in crisp, bright color again. Here’s what to know about cataract symptoms and removal.
Getting in front of cancer
Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But a number of scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed what kind of prognosis many of these patients will have.